¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"cellular immune theory"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • immune deposit
    ¸é¿ªÄ§Âø¹°
  • immune deviation
    ¸é¿ª¹ÝÀÀÄ¡¿ìħ
  • immune disorder
    ¸é¿ªÁúȯ, ¸é¿ªÀå¾Ö
  • immune deposit disease
    ¸é¿ªÄ§Âøº´
  • immune-complex disease
    ¸é¿ªº¹ÇÕüº´
  • immune electrophoresis
    ¸é¿ªÀü±âÀ̵¿¹ý
  • immune elimination
    ¸é¿ª¿øÁ¦°Å
  • human rabies immune globulin
    »ç¶÷¹ÌÄ£°³º´¸é¿ª±Û·ÎºÒ¸°
  • immune globulin
    ¸é¿ª±Û·ÎºÒ¸°
  • immune human serum globulin
    (¢¡immune globulin) ¸é¿ª±Û·ÎºÒ¸°
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
  • immune hemolysis
    ¸é¿ª¿ëÇ÷
  • immune adherence hemagglutination
    ¸é¿ªºÎÂøÀûÇ÷±¸ÀÀÁý
  • immune complex mediated hypersensitivity
    ¸é¿ªº¹ÇÕü¸Å°³°ú¹Î
  • immune-mediated hemolysis
    ¸é¿ª¸Å°³¿ëÇ÷
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • immune network
    ¸é¿ª¸Á
  • immune neutropenia
    ¸é¿ªÈ£Áß±¸°¨¼ÒÁõ.
  • immune phenomenon
    ¸é¿ªÇö»ó.
  • immune polysaccharides
    ¸é¿ª(¼º) ´Ù´ç·ù(¡­ÒýӨ׾).
  • immune precipitate
    ¸é¿ªÄ§°­¹°
  • immune protein
    ¸é¿ª´Ü¹éÁú.
  • immune reaction
    ¸é¿ª¹ÝÀÀ.
  • immune reactivity
    ¸é¿ª¹ÝÀÀ¼º.
  • immune response
    ¸é¿ªÀÀ´ä.
  • immune response
    ¸é¿ª¹ÝÀÀ
  • immune response
    ¸é¿ªÀÀ´ä.
  • immune response
    ¸é¿ªÀÀ´ä.
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ.
  • immune response gene
    ¸é¿ª¹ÝÀÀÀ¯ÀüÀÚ
  • immune response suppression
    ¸é¿ª¹ÝÀÀ¾ïÁ¦<--¾ï¾Ð>
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • immune bacteriolysis
    ¸é¿ª¿ë±Õ.
  • immune cause (hemolytic anemia)
    ¸é¿ª¿øÀÎ(¿ëÇ÷¼ººóÇ÷)
  • immune clearance
    ¸é¿ªÅ¬¸®¾î·±½º.
  • immune clearance
    ¸é¿ªÅ¬¸®¾î·±½º.
  • immune complex
    ¸é¿ªº¹ÇÕü
  • immune complex
    ¸é¿ªº¹ÇÕü.
  • immune complex disease
    ¸é¿ªº¹ÇÕüº´.
  • immune complex measurement
    ¸é¿ªº¹ÇÕÃ¼ÃøÁ¤
  • immune complex mediated hypersensitivity
    ¸é¿ªº¹ÇÕü¸Å°³ °ú¹Î¹ÝÀÀ
  • immune complex urticaria
    ¸é¿ªº¹Çյε巯±â
  • immune complex vasculitis
    ¸é¿ªº¹ÇÕüÇ÷°ü¿°
  • immune complex vasculitis
    ¸é¿ªº¹ÇÕü¼º Ç÷°ü¿°(Øóæ¹ÜÜùêô÷àõ úìηæú)
  • immune complex-mediated
    ¸é¿ªº¹ÇÕü¸Å°³°ú¹ÎÁõ(Øóæ¹ÜÜùêô÷ØÚ˿ΦÚÂñø)
  • immune complexes
    ¸é¿ªº¹ÇÕü(Øóæ¹ÜÜùêô÷)
  • immune cytolysis
    ¸é¿ª¼¼Æ÷¿ëÇØ.
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • recapitulation theory
    ¹Ýº¹ ¹ß»ý·Ð(ÚãÜÖÛ¡ßæÖå)
  • selective theory
    ¼±ÅÃÀÌ·Ð(àÔ÷É×âÖå)
  • self-marker theory
    ÀÚ±â Ç¥Áö ÀÌ·Ð(í»Ðùøöò½×âÖå)
  • serial symbiosis theory
    ¿¬¼Ó°ø»ý·Ð(Ö§áÙÍìßæÖå)
  • side chain theory
    °ç°¡Áö ÀÌ·Ð(×âÖå)
  • Smithie's theory
    ½º¹ÌƼ ÀÌ·Ð(×âÖå)
  • somatic mutation theory
    ü¼¼Æ÷ º¯ÀÌÀÌ·Ð(ô÷á¬øàܨì¶×âÖå)
  • somatic recombination theory
    ü¼¼Æ÷ ÀçÁ¶ÇÕ ÀÌ·Ð(ô÷á¬øàî¢ðÚùê×âÖå)
  • somatic theory
    ü¼¼Æ÷ ÀÌ·Ð(ô÷á¬øà×âÖå)
  • specific interaction theory
    ƯÀÌ »óÈ£ÀÛ¿ëÀÌ·Ð(÷åì¶ßÓû»íÂéÄ×âÖå)
  • stereochemical theory
    ÀÔüȭÇÐ ÀÌ·Ð (Ø¡ô÷ûùùÊ×âÖå)
  • Sterzl theory
    ½ºÅÍÁñ ÀÌ·Ð (×âÖå)
  • target theory
    Ç¥ÀûÀÌ·Ð (øöîÜ×âÖå)
  • template theory
    ƲÀÌ·Ð (ìµÖå)
  • theory
    ÀÌ·Ð(×âÖå)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
AIHA Auto-Immune Hemolytic Anemia
CIC Circulating Immune Complexes
ICs Immune Complexes
ISG Immune Serum Globulin
ITP Idiopathic(Immune) Thrombocytopenic Purpura
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
CRBP(II) Cellular retinol-binding protein type II
ECM Extra Cellular Matrix
LDCC Lectin-dependent cellular cytotoxicity
MICC Mitogen induced cellular cytotoxicity
PCNA Proliferating Cellular Nuclear Antigen
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • theory of causation
    ¿øÀηÐ
  • trichromatic theory
    »ï»ö¼³, »ï¿ø»ö¼³
  • vascular theory
    Ç÷°ü ÀÌ·Ð
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
tetanus immune globulin <protein> A protein antibody to tetanus toxin, given as passive immunity for those lacking any prior tetanus vaccination.
(27 Sep 1997)
zoster immune globulin A globulin fraction of pooled plasma from individuals who have recovered from herpes zoster; used prophylactically and therapeutically for varicella.
(05 Mar 2000)
Abbe theory of image formation <optics, physics> Abbe's theory is based on the fact that a non-self-luminous particle, which is illuminated by an extraneous source, gives rise to diffracted light rays, in addition to the dioptric pencil.
He stated that to form a good microscopical image as many of the diffracted rays as possible should be intercepted by the objective. With closely ruled lines, his theory is easily demonstrated by observing the back lens of the objective, for here the diffracted rays can be observed directly if the aperture diaphragm is closed. It can be shown that, when the illumination is arranged to exclude the diffracted images, resolution is lost.
(11 Mar 1998)
adsorption theory of narcosis That a drug becomes concentrated at the surface of the cell as a result of adsorption, and thus alters permeability and metabolism.
(05 Mar 2000)
Altmann's theory A theory that protoplasm consists of granular particles (called bioblasts) that are clustered and enclosed in indifferent matter.
(05 Mar 2000)
Arrhenius-Madsen theory That the reaction of an antigen with its antibody is a reversible reaction, the equilibrium being determined according to the law of mass action by the concentrations of the reacting substances.
(05 Mar 2000)
atomic theory That chemical compounds are formed by the union of atoms in certain definite proportions; in its modern form, first advanced in 1803 by John Dalton.
(05 Mar 2000)
Baeyer's theory That carbon bonds are set at fixed angles (109
balance theory In social psychology, a theory which assumes that steady and unsteady states can be specified for cognitive units, such as an individual and his or her attitudes or acts, and that such units tend to seek steady states (balance); e.g., balance exists when both parts of a unit are evaluated the same, but disequilibrium arises when both parts are not evaluated the same, which causes either cognitive reevaluation of the parts or their segregation.
See: cognitive dissonance theory, consistency principle.
(05 Mar 2000)
beta-oxidation-condensation theory <biochemistry> That the two carbon fragments split from the fatty acid molecule by beta-oxidation are converted to acetic acid and then condensed to acetoacetic acid.
(05 Mar 2000)
Bohr's theory That spectrum lines are produced 1) by the quantised emission of radiant energy when electrons drop from an orbit of a higher to one of a lower energy level, or 2) by absorption of radiation when an electron rises from a lower to a higher energy level.
(05 Mar 2000)
Bordeau theory That each organ of the body manufactured a specific humor which it secreted into the bloodstream.
(05 Mar 2000)
Bowman's theory That the urine is formed by passive filtration through the glomeruli and secretion by the epithelium of the tubules, the water and salts being separated from the plasma in the former situation, the urea and other urinary constituents in the latter. Parts of this theory are now known to be wrong.
(05 Mar 2000)
Bronsted theory That an acid is a substance, charged or uncharged, liberating hydrogen ions in solution, and that a base is a substance that removes them from solution (e.g., NH4+, CH3COOH, and HSO4- are acids; NH3, CH3COO-, and SO4- are bases); useful in the concept of weak electrolytes and buffers.
Compare: Bronsted acid, Bronsted base.
(05 Mar 2000)
Burn and Rand theory That stimulation of sympathetic fibres results first in the production of acetylcholine in the postganglionic nerve endings, which then release norepinephrine to act on the active site of the effector cell.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á